Apo-Risedronate 35 mg (Risedronate Sodium (Risedronate Sodium Hemipentahydrate) TABLET) 35 MG

APO-Risedronate 35 mg tablets are a medication used to treat osteoporosis and improve bone density. This oral tablet helps maintain bone health and reduce fracture risk.

Strength

35 MG

Pack Size

4/30

Manufacturer / TM Owner

APOTEX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

APO-Risedronate 35 mg tablets are primarily used to treat osteoporosis in postmenopausal women. This medication works by slowing bone loss, helping to maintain bone density and reduce the risk of fractures. It is often prescribed for individuals with low bone mass or those at risk of osteoporosis-related bone breaks. The active ingredient, risedronate sodium, is a bisphosphonate that helps to strengthen bones and prevent further deterioration.

Side Effects

Common effects of APO-Risedronate 35 mg tablets may include mild stomach upset, heartburn, or diarrhea. Some users might experience muscle or joint pain. These effects are generally mild and temporary. If any severe or persistent symptoms occur, it is important to consult a healthcare provider.

Precautions & Warnings

APO-Risedronate 35 mg tablets should be taken with a full glass of water and while standing or sitting upright. It is important to avoid lying down for at least 30 minutes after taking the tablet to prevent irritation of the esophagus. Individuals with certain medical conditions, such as low calcium levels or severe kidney problems, should use this medication with caution. Always follow the advice of a healthcare professional regarding the use of this medication.

Avoid Interactions

APO-Risedronate 35 mg tablets may interact with certain medications, including calcium supplements, antacids, and other oral medications. It is important to take this medication on an empty stomach, at least 30 minutes before eating or drinking anything other than water. Alcohol and certain foods may also affect the absorption of risedronate sodium, so it is advisable to avoid them around the time of taking this medication.

Frequently Asked Questions

APO-Risedronate 35 mg tablets are used to treat osteoporosis and improve bone density in postmenopausal women.

Take APO-Risedronate 35 mg tablets with a full glass of water while standing or sitting upright, and avoid lying down for at least 30 minutes afterward.

Common side effects may include mild stomach upset, heartburn, diarrhea, and muscle or joint pain.

APO-Risedronate 35 mg may interact with certain medications, so it is important to consult a healthcare provider before combining it with other treatments.

Individuals with certain medical conditions, such as low calcium levels or severe kidney problems, should use APO-Risedronate 35 mg with caution.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.